Nucleic Acid Based Gene Therapy Market, Global Outlook and Forecast 2022-2028

April 2022 | 64 pages | ID: N1A1552103A9EN
Market Monitor Global

Abstracts

Gene therapy is used for correcting defective genes that are responsible for disease development. Moreover, nucleic acid-based therapeutics are used to treat genetic disorders and diseases for which there exists no permanent cure such as anaemia, sickle cell, cystic fibrosis, diabetes, and thalassemia.

This report contains market size and forecasts of Nucleic Acid Based Gene Therapy in Global, including the following market information:

Global Nucleic Acid Based Gene Therapy Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Nucleic Acid Based Gene Therapy market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Anti-Sence and Anti-Gene Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Nucleic Acid Based Gene Therapy include Wave Life Sciences, Imugene, Sarepta Therapeutics, Alnylam Pharmaceuticals, Ionis Pharmaceuticals, Moderna, BioNTech, Nutcracker Therapeutics and Deep Genomics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Nucleic Acid Based Gene Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Nucleic Acid Based Gene Therapy Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Nucleic Acid Based Gene Therapy Market Segment Percentages, by Type, 2021 (%)

• Anti-Sence and Anti-Gene
• Short Inhibitory Sequences
• Gene Transfer Therapy
• Nucleoside Analogs
• Ribozymes
• Aptamers
• Others

Global Nucleic Acid Based Gene Therapy Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Nucleic Acid Based Gene Therapy Market Segment Percentages, by Application, 2021 (%)

• Hospitals and Clinics
• Academic and Research Institutes
• Others

Global Nucleic Acid Based Gene Therapy Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Nucleic Acid Based Gene Therapy Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Nucleic Acid Based Gene Therapy revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Nucleic Acid Based Gene Therapy revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Wave Life Sciences
• Imugene
• Sarepta Therapeutics
• Alnylam Pharmaceuticals
• Ionis Pharmaceuticals
• Moderna
• BioNTech
• Nutcracker Therapeutics
• Deep Genomics
• Sirnaomics
• Laronde
• Abogen Biosciences

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Nucleic Acid Based Gene Therapy Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Nucleic Acid Based Gene Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL NUCLEIC ACID BASED GENE THERAPY OVERALL MARKET SIZE

2.1 Global Nucleic Acid Based Gene Therapy Market Size: 2021 VS 2028
2.2 Global Nucleic Acid Based Gene Therapy Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Nucleic Acid Based Gene Therapy Players in Global Market
3.2 Top Global Nucleic Acid Based Gene Therapy Companies Ranked by Revenue
3.3 Global Nucleic Acid Based Gene Therapy Revenue by Companies
3.4 Top 3 and Top 5 Nucleic Acid Based Gene Therapy Companies in Global Market, by Revenue in 2021
3.5 Global Companies Nucleic Acid Based Gene Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Nucleic Acid Based Gene Therapy Players in Global Market
  3.6.1 List of Global Tier 1 Nucleic Acid Based Gene Therapy Companies
  3.6.2 List of Global Tier 2 and Tier 3 Nucleic Acid Based Gene Therapy Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Nucleic Acid Based Gene Therapy Market Size Markets, 2021 & 2028
  4.1.2 Anti-Sence and Anti-Gene
  4.1.3 Short Inhibitory Sequences
  4.1.4 Gene Transfer Therapy
  4.1.5 Nucleoside Analogs
  4.1.6 Ribozymes
  4.1.7 Aptamers
  4.1.8 Others
4.2 By Type - Global Nucleic Acid Based Gene Therapy Revenue & Forecasts
  4.2.1 By Type - Global Nucleic Acid Based Gene Therapy Revenue, 2017-2022
  4.2.2 By Type - Global Nucleic Acid Based Gene Therapy Revenue, 2023-2028
  4.2.3 By Type - Global Nucleic Acid Based Gene Therapy Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Nucleic Acid Based Gene Therapy Market Size, 2021 & 2028
  5.1.2 Hospitals and Clinics
  5.1.3 Academic and Research Institutes
  5.1.4 Others
5.2 By Application - Global Nucleic Acid Based Gene Therapy Revenue & Forecasts
  5.2.1 By Application - Global Nucleic Acid Based Gene Therapy Revenue, 2017-2022
  5.2.2 By Application - Global Nucleic Acid Based Gene Therapy Revenue, 2023-2028
  5.2.3 By Application - Global Nucleic Acid Based Gene Therapy Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Nucleic Acid Based Gene Therapy Market Size, 2021 & 2028
6.2 By Region - Global Nucleic Acid Based Gene Therapy Revenue & Forecasts
  6.2.1 By Region - Global Nucleic Acid Based Gene Therapy Revenue, 2017-2022
  6.2.2 By Region - Global Nucleic Acid Based Gene Therapy Revenue, 2023-2028
  6.2.3 By Region - Global Nucleic Acid Based Gene Therapy Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Nucleic Acid Based Gene Therapy Revenue, 2017-2028
  6.3.2 US Nucleic Acid Based Gene Therapy Market Size, 2017-2028
  6.3.3 Canada Nucleic Acid Based Gene Therapy Market Size, 2017-2028
  6.3.4 Mexico Nucleic Acid Based Gene Therapy Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Nucleic Acid Based Gene Therapy Revenue, 2017-2028
  6.4.2 Germany Nucleic Acid Based Gene Therapy Market Size, 2017-2028
  6.4.3 France Nucleic Acid Based Gene Therapy Market Size, 2017-2028
  6.4.4 U.K. Nucleic Acid Based Gene Therapy Market Size, 2017-2028
  6.4.5 Italy Nucleic Acid Based Gene Therapy Market Size, 2017-2028
  6.4.6 Russia Nucleic Acid Based Gene Therapy Market Size, 2017-2028
  6.4.7 Nordic Countries Nucleic Acid Based Gene Therapy Market Size, 2017-2028
  6.4.8 Benelux Nucleic Acid Based Gene Therapy Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Nucleic Acid Based Gene Therapy Revenue, 2017-2028
  6.5.2 China Nucleic Acid Based Gene Therapy Market Size, 2017-2028
  6.5.3 Japan Nucleic Acid Based Gene Therapy Market Size, 2017-2028
  6.5.4 South Korea Nucleic Acid Based Gene Therapy Market Size, 2017-2028
  6.5.5 Southeast Asia Nucleic Acid Based Gene Therapy Market Size, 2017-2028
  6.5.6 India Nucleic Acid Based Gene Therapy Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Nucleic Acid Based Gene Therapy Revenue, 2017-2028
  6.6.2 Brazil Nucleic Acid Based Gene Therapy Market Size, 2017-2028
  6.6.3 Argentina Nucleic Acid Based Gene Therapy Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Nucleic Acid Based Gene Therapy Revenue, 2017-2028
  6.7.2 Turkey Nucleic Acid Based Gene Therapy Market Size, 2017-2028
  6.7.3 Israel Nucleic Acid Based Gene Therapy Market Size, 2017-2028
  6.7.4 Saudi Arabia Nucleic Acid Based Gene Therapy Market Size, 2017-2028
  6.7.5 UAE Nucleic Acid Based Gene Therapy Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Wave Life Sciences
  7.1.1 Wave Life Sciences Corporate Summary
  7.1.2 Wave Life Sciences Business Overview
  7.1.3 Wave Life Sciences Nucleic Acid Based Gene Therapy Major Product Offerings
  7.1.4 Wave Life Sciences Nucleic Acid Based Gene Therapy Revenue in Global Market (2017-2022)
  7.1.5 Wave Life Sciences Key News
7.2 Imugene
  7.2.1 Imugene Corporate Summary
  7.2.2 Imugene Business Overview
  7.2.3 Imugene Nucleic Acid Based Gene Therapy Major Product Offerings
  7.2.4 Imugene Nucleic Acid Based Gene Therapy Revenue in Global Market (2017-2022)
  7.2.5 Imugene Key News
7.3 Sarepta Therapeutics
  7.3.1 Sarepta Therapeutics Corporate Summary
  7.3.2 Sarepta Therapeutics Business Overview
  7.3.3 Sarepta Therapeutics Nucleic Acid Based Gene Therapy Major Product Offerings
  7.3.4 Sarepta Therapeutics Nucleic Acid Based Gene Therapy Revenue in Global Market (2017-2022)
  7.3.5 Sarepta Therapeutics Key News
7.4 Alnylam Pharmaceuticals
  7.4.1 Alnylam Pharmaceuticals Corporate Summary
  7.4.2 Alnylam Pharmaceuticals Business Overview
  7.4.3 Alnylam Pharmaceuticals Nucleic Acid Based Gene Therapy Major Product Offerings
  7.4.4 Alnylam Pharmaceuticals Nucleic Acid Based Gene Therapy Revenue in Global Market (2017-2022)
  7.4.5 Alnylam Pharmaceuticals Key News
7.5 Ionis Pharmaceuticals
  7.5.1 Ionis Pharmaceuticals Corporate Summary
  7.5.2 Ionis Pharmaceuticals Business Overview
  7.5.3 Ionis Pharmaceuticals Nucleic Acid Based Gene Therapy Major Product Offerings
  7.5.4 Ionis Pharmaceuticals Nucleic Acid Based Gene Therapy Revenue in Global Market (2017-2022)
  7.5.5 Ionis Pharmaceuticals Key News
7.6 Moderna
  7.6.1 Moderna Corporate Summary
  7.6.2 Moderna Business Overview
  7.6.3 Moderna Nucleic Acid Based Gene Therapy Major Product Offerings
  7.6.4 Moderna Nucleic Acid Based Gene Therapy Revenue in Global Market (2017-2022)
  7.6.5 Moderna Key News
7.7 BioNTech
  7.7.1 BioNTech Corporate Summary
  7.7.2 BioNTech Business Overview
  7.7.3 BioNTech Nucleic Acid Based Gene Therapy Major Product Offerings
  7.7.4 BioNTech Nucleic Acid Based Gene Therapy Revenue in Global Market (2017-2022)
  7.7.5 BioNTech Key News
7.8 Nutcracker Therapeutics
  7.8.1 Nutcracker Therapeutics Corporate Summary
  7.8.2 Nutcracker Therapeutics Business Overview
  7.8.3 Nutcracker Therapeutics Nucleic Acid Based Gene Therapy Major Product Offerings
  7.8.4 Nutcracker Therapeutics Nucleic Acid Based Gene Therapy Revenue in Global Market (2017-2022)
  7.8.5 Nutcracker Therapeutics Key News
7.9 Deep Genomics
  7.9.1 Deep Genomics Corporate Summary
  7.9.2 Deep Genomics Business Overview
  7.9.3 Deep Genomics Nucleic Acid Based Gene Therapy Major Product Offerings
  7.9.4 Deep Genomics Nucleic Acid Based Gene Therapy Revenue in Global Market (2017-2022)
  7.9.5 Deep Genomics Key News
7.10 Sirnaomics
  7.10.1 Sirnaomics Corporate Summary
  7.10.2 Sirnaomics Business Overview
  7.10.3 Sirnaomics Nucleic Acid Based Gene Therapy Major Product Offerings
  7.10.4 Sirnaomics Nucleic Acid Based Gene Therapy Revenue in Global Market (2017-2022)
  7.10.5 Sirnaomics Key News
7.11 Laronde
  7.11.1 Laronde Corporate Summary
  7.11.2 Laronde Business Overview
  7.11.3 Laronde Nucleic Acid Based Gene Therapy Major Product Offerings
  7.11.4 Laronde Nucleic Acid Based Gene Therapy Revenue in Global Market (2017-2022)
  7.11.5 Laronde Key News
7.12 Abogen Biosciences
  7.12.1 Abogen Biosciences Corporate Summary
  7.12.2 Abogen Biosciences Business Overview
  7.12.3 Abogen Biosciences Nucleic Acid Based Gene Therapy Major Product Offerings
  7.12.4 Abogen Biosciences Nucleic Acid Based Gene Therapy Revenue in Global Market (2017-2022)
  7.12.5 Abogen Biosciences Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Nucleic Acid Based Gene Therapy Market Opportunities & Trends in Global Market
Table 2. Nucleic Acid Based Gene Therapy Market Drivers in Global Market
Table 3. Nucleic Acid Based Gene Therapy Market Restraints in Global Market
Table 4. Key Players of Nucleic Acid Based Gene Therapy in Global Market
Table 5. Top Nucleic Acid Based Gene Therapy Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Nucleic Acid Based Gene Therapy Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Nucleic Acid Based Gene Therapy Revenue Share by Companies, 2017-2022
Table 8. Global Companies Nucleic Acid Based Gene Therapy Product Type
Table 9. List of Global Tier 1 Nucleic Acid Based Gene Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Nucleic Acid Based Gene Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Nucleic Acid Based Gene Therapy Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Nucleic Acid Based Gene Therapy Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Nucleic Acid Based Gene Therapy Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Nucleic Acid Based Gene Therapy Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Nucleic Acid Based Gene Therapy Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Nucleic Acid Based Gene Therapy Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Nucleic Acid Based Gene Therapy Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Nucleic Acid Based Gene Therapy Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Nucleic Acid Based Gene Therapy Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Nucleic Acid Based Gene Therapy Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Nucleic Acid Based Gene Therapy Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Nucleic Acid Based Gene Therapy Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Nucleic Acid Based Gene Therapy Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Nucleic Acid Based Gene Therapy Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Nucleic Acid Based Gene Therapy Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Nucleic Acid Based Gene Therapy Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Nucleic Acid Based Gene Therapy Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Nucleic Acid Based Gene Therapy Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Nucleic Acid Based Gene Therapy Revenue, (US$, Mn), 2023-2028
Table 30. Wave Life Sciences Corporate Summary
Table 31. Wave Life Sciences Nucleic Acid Based Gene Therapy Product Offerings
Table 32. Wave Life Sciences Nucleic Acid Based Gene Therapy Revenue (US$, Mn), (2017-2022)
Table 33. Imugene Corporate Summary
Table 34. Imugene Nucleic Acid Based Gene Therapy Product Offerings
Table 35. Imugene Nucleic Acid Based Gene Therapy Revenue (US$, Mn), (2017-2022)
Table 36. Sarepta Therapeutics Corporate Summary
Table 37. Sarepta Therapeutics Nucleic Acid Based Gene Therapy Product Offerings
Table 38. Sarepta Therapeutics Nucleic Acid Based Gene Therapy Revenue (US$, Mn), (2017-2022)
Table 39. Alnylam Pharmaceuticals Corporate Summary
Table 40. Alnylam Pharmaceuticals Nucleic Acid Based Gene Therapy Product Offerings
Table 41. Alnylam Pharmaceuticals Nucleic Acid Based Gene Therapy Revenue (US$, Mn), (2017-2022)
Table 42. Ionis Pharmaceuticals Corporate Summary
Table 43. Ionis Pharmaceuticals Nucleic Acid Based Gene Therapy Product Offerings
Table 44. Ionis Pharmaceuticals Nucleic Acid Based Gene Therapy Revenue (US$, Mn), (2017-2022)
Table 45. Moderna Corporate Summary
Table 46. Moderna Nucleic Acid Based Gene Therapy Product Offerings
Table 47. Moderna Nucleic Acid Based Gene Therapy Revenue (US$, Mn), (2017-2022)
Table 48. BioNTech Corporate Summary
Table 49. BioNTech Nucleic Acid Based Gene Therapy Product Offerings
Table 50. BioNTech Nucleic Acid Based Gene Therapy Revenue (US$, Mn), (2017-2022)
Table 51. Nutcracker Therapeutics Corporate Summary
Table 52. Nutcracker Therapeutics Nucleic Acid Based Gene Therapy Product Offerings
Table 53. Nutcracker Therapeutics Nucleic Acid Based Gene Therapy Revenue (US$, Mn), (2017-2022)
Table 54. Deep Genomics Corporate Summary
Table 55. Deep Genomics Nucleic Acid Based Gene Therapy Product Offerings
Table 56. Deep Genomics Nucleic Acid Based Gene Therapy Revenue (US$, Mn), (2017-2022)
Table 57. Sirnaomics Corporate Summary
Table 58. Sirnaomics Nucleic Acid Based Gene Therapy Product Offerings
Table 59. Sirnaomics Nucleic Acid Based Gene Therapy Revenue (US$, Mn), (2017-2022)
Table 60. Laronde Corporate Summary
Table 61. Laronde Nucleic Acid Based Gene Therapy Product Offerings
Table 62. Laronde Nucleic Acid Based Gene Therapy Revenue (US$, Mn), (2017-2022)
Table 63. Abogen Biosciences Corporate Summary
Table 64. Abogen Biosciences Nucleic Acid Based Gene Therapy Product Offerings
Table 65. Abogen Biosciences Nucleic Acid Based Gene Therapy Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Nucleic Acid Based Gene Therapy Segment by Type in 2021
Figure 2. Nucleic Acid Based Gene Therapy Segment by Application in 2021
Figure 3. Global Nucleic Acid Based Gene Therapy Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Nucleic Acid Based Gene Therapy Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Nucleic Acid Based Gene Therapy Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Nucleic Acid Based Gene Therapy Revenue in 2021
Figure 8. By Type - Global Nucleic Acid Based Gene Therapy Revenue Market Share, 2017-2028
Figure 9. By Application - Global Nucleic Acid Based Gene Therapy Revenue Market Share, 2017-2028
Figure 10. By Region - Global Nucleic Acid Based Gene Therapy Revenue Market Share, 2017-2028
Figure 11. By Country - North America Nucleic Acid Based Gene Therapy Revenue Market Share, 2017-2028
Figure 12. US Nucleic Acid Based Gene Therapy Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Nucleic Acid Based Gene Therapy Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Nucleic Acid Based Gene Therapy Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Nucleic Acid Based Gene Therapy Revenue Market Share, 2017-2028
Figure 16. Germany Nucleic Acid Based Gene Therapy Revenue, (US$, Mn), 2017-2028
Figure 17. France Nucleic Acid Based Gene Therapy Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Nucleic Acid Based Gene Therapy Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Nucleic Acid Based Gene Therapy Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Nucleic Acid Based Gene Therapy Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Nucleic Acid Based Gene Therapy Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Nucleic Acid Based Gene Therapy Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Nucleic Acid Based Gene Therapy Revenue Market Share, 2017-2028
Figure 24. China Nucleic Acid Based Gene Therapy Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Nucleic Acid Based Gene Therapy Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Nucleic Acid Based Gene Therapy Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Nucleic Acid Based Gene Therapy Revenue, (US$, Mn), 2017-2028
Figure 28. India Nucleic Acid Based Gene Therapy Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Nucleic Acid Based Gene Therapy Revenue Market Share, 2017-2028
Figure 30. Brazil Nucleic Acid Based Gene Therapy Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Nucleic Acid Based Gene Therapy Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Nucleic Acid Based Gene Therapy Revenue Market Share, 2017-2028
Figure 33. Turkey Nucleic Acid Based Gene Therapy Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Nucleic Acid Based Gene Therapy Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Nucleic Acid Based Gene Therapy Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Nucleic Acid Based Gene Therapy Revenue, (US$, Mn), 2017-2028
Figure 37. Wave Life Sciences Nucleic Acid Based Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Imugene Nucleic Acid Based Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Sarepta Therapeutics Nucleic Acid Based Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Alnylam Pharmaceuticals Nucleic Acid Based Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Ionis Pharmaceuticals Nucleic Acid Based Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Moderna Nucleic Acid Based Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. BioNTech Nucleic Acid Based Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Nutcracker Therapeutics Nucleic Acid Based Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Deep Genomics Nucleic Acid Based Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Sirnaomics Nucleic Acid Based Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Laronde Nucleic Acid Based Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Abogen Biosciences Nucleic Acid Based Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)